Business
Notice of Results
Notice of Results.
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n11 July 2024\n\nECO Animal Health Group plc\n(\"ECO\" or the \"Company\")\n \nNotice of Results\nECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it will issue its financial results for the year ended 31 March 2024 on 15 July 2024.\nInvestor Presentation\nDavid Hallas, CEO, and Christopher Wilks, CFO, will host a virtual briefing and Q&A session for analysts at 11:00 BST on the day of results.\nFor further information about the analyst presentation, please contact [email protected].\n-Ends-\nFor further information please contact:\n \n\n\n\n\n\n\n\n\nECO Animal Health Group plc\nDavid Hallas (CEO)\nChristopher Wilks (CFO)\n\n\n\n020 8447 8899\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhil Davies\nSam Butcher\n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n\n\n020 7597 5970\n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\nICR Consilium (Financial PR)\nMary-Jane Elliott\nJessica Hodgson\n\n\n020 3709 5700\[email protected]\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout ECO Animal Health\nECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.\n \nHeadquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.\n \nOur lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. \nClick here for more information: https://ecoanimalhealth.com\n \n\n","length":5102,"tagName":"div"}]